Literature DB >> 27079495

Ketamine's Antidepressant Actions: Potential Mechanisms in the Primate Medial Prefrontal Circuits That Represent Aversive Experience.

Amy F T Arnsten1, John D Murray2, Hyojung Seo3, Daeyeol Lee3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27079495      PMCID： PMC5458412          DOI： 10.1016/j.biopsych.2016.02.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

1.  Large-Scale Persistent Network Reconfiguration Induced by Ketamine in Anesthetized Monkeys: Relevance to Mood Disorders.

Authors:  Qian Lv; Liqin Yang; Guoliang Li; Zhiwei Wang; Zhuangming Shen; Wenwen Yu; Qinying Jiang; Baoyu Hou; Jian Pu; Hailan Hu; Zheng Wang
Journal:  Biol Psychiatry       Date:  2015-02-27       Impact factor: 13.382

2.  Deep brain stimulation for treatment-resistant depression.

Authors:  Helen S Mayberg; Andres M Lozano; Valerie Voon; Heather E McNeely; David Seminowicz; Clement Hamani; Jason M Schwalb; Sidney H Kennedy
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

Review 3.  Sleep and arousal: thalamocortical mechanisms.

Authors:  D A McCormick; T Bal
Journal:  Annu Rev Neurosci       Date:  1997       Impact factor: 12.449

4.  NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex.

Authors:  Min Wang; Yang Yang; Ching-Jung Wang; Nao J Gamo; Lu E Jin; James A Mazer; John H Morrison; Xiao-Jing Wang; Amy F T Arnsten
Journal:  Neuron       Date:  2013-02-20       Impact factor: 17.173

Review 5.  Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish.

Authors:  Lewis A Opler; Mark G A Opler; Amy F T Arnsten
Journal:  CNS Spectr       Date:  2015-01-26       Impact factor: 3.790

6.  Behavioral and neural changes after gains and losses of conditioned reinforcers.

Authors:  Hyojung Seo; Daeyeol Lee
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

7.  Regionally distinct processing of rewards and punishments by the primate ventromedial prefrontal cortex.

Authors:  Ilya E Monosov; Okihide Hikosaka
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

Review 8.  Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.

Authors:  John H Krystal; Gerard Sanacora; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-06-15       Impact factor: 13.382

9.  A randomized controlled trial of intranasal ketamine in major depressive disorder.

Authors:  Kyle A B Lapidus; Cara F Levitch; Andrew M Perez; Jess W Brallier; Michael K Parides; Laili Soleimani; Adriana Feder; Dan V Iosifescu; Dennis S Charney; James W Murrough
Journal:  Biol Psychiatry       Date:  2014-04-03       Impact factor: 13.382

10.  Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans.

Authors:  N R Driesen; G McCarthy; Z Bhagwagar; M Bloch; V Calhoun; D C D'Souza; R Gueorguieva; G He; R Ramachandran; R F Suckow; A Anticevic; P T Morgan; J H Krystal
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992
  10 in total
  2 in total

1.  Fluoroethylnormemantine, A Novel Derivative of Memantine, Facilitates Extinction Learning Without Sensorimotor Deficits.

Authors:  Briana K Chen; Gwenaëlle Le Pen; Adam Eckmier; Gilles Rubinstenn; Therese M Jay; Christine A Denny
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176

Review 2.  Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.

Authors:  Bashkim Kadriu; Laura Musazzi; Ioline D Henter; Morgan Graves; Maurizio Popoli; Carlos A Zarate
Journal:  Int J Neuropsychopharmacol       Date:  2019-02-01       Impact factor: 5.176
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.